ライフサイエンスコーパス: osteonecrosis of the jaw

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 ust be instituted to avoid renal toxicity or osteonecrosis of the jaw.

2 e pathogenesis of the bisphosphonate-induced osteonecrosis of the jaw.

3 ic sites, such as the bisphosphonate-related osteonecrosis of the jaw.

4 zoledronic acid, who unexpectedly developed osteonecrosis of the jaw.

5 ons, tumor metastasis and infections such as osteonecrosis of the jaw.

6 el alendronate period, adjudicated events of osteonecrosis of the jaw (1 event each in the romosozuma

7 as associated with higher rates of confirmed osteonecrosis of the jaw (35 [4%]) than was clodronic ac

8 sion under Adalimumab therapy presented with osteonecrosis of the jaw after suspended oral and intrav

9 tients analysable for safety, three (1%) had osteonecrosis of the jaw and 15 (5%) hypocalcaemia.

10 Osteonecrosis of the jaw and atypical femur fractures ha

11 ents were similar in both groups, except for osteonecrosis of the jaw and hypocalcaemia.

12 or hypocalcemia, and there were no cases of osteonecrosis of the jaw and no adverse reactions to the

13 Risk factors for osteonecrosis of the jaw and renal impairment should be

14 Serious cardiovascular adverse events, osteonecrosis of the jaw, and atypical femoral fractures

15 Bisphosphonate-associated osteonecrosis of the jaw (BONJ) is a morbid bone disease

16 etio-pathogenesis of bisphosphonate-induced osteonecrosis of the jaw (BONJ).

17 Bisphosphonate-related osteonecrosis of the jaw (BRONJ) commonly occurs in indi

18 Bisphosphonate-associated osteonecrosis of the jaw (BRONJ) is a feared side effect

19 is is associated with bisphosphonate-related osteonecrosis of the jaw (BRONJ).

20 te proactive adjudication of every potential osteonecrosis of the jaw by an international expert pane

21 acid group, there were 17 confirmed cases of osteonecrosis of the jaw (cumulative incidence, 1.1%; 95

22 Despite these benefits, osteonecrosis of the jaws has recently emerged as a sign

23 33 cases of suspected osteonecrosis of the jaw have been reported, with 26 con

24 d case series described clinical features of osteonecrosis of the jaw in patients with cancer who wer

25 There was one possible case of osteonecrosis of the jaw in the clodronate group.

26 eons described 104 patients with cancer with osteonecrosis of the jaw in the medical literature and i

27 Osteonecrosis of the jaws is a recently described advers

28 res indicate worse disability), incidence of osteonecrosis of the jaw, kidney dysfunction, skeletal m

29 Medication-related osteonecrosis of the jaw (MRONJ), although initially bel

30 Osteonecrosis of the jaw occurred at similarly low rates

31 Osteonecrosis of the jaw occurred infrequently (2.0%, de

32 The incidence of osteonecrosis of the jaw (ONJ) in the population is low,

33 Osteonecrosis of the jaw (ONJ), a side-effect of bisphos

34 ta regarding atrial fibrillation, bone pain, osteonecrosis of the jaw (ONJ), atypical fractures, and

35 issues, inappropriate femoral fractures, and osteonecrosis of the jaw (ONJ), the pathophysiological m

36 teriparatide administration in patients with osteonecrosis of the jaw (ONJ).

37 ssociated with the occasional development of osteonecrosis of the jaw (ONJ).

38 ded the guideline to include a discussion of osteonecrosis of the jaw (ONJ).

39 dical benefits seem to outweigh the risk for osteonecrosis of the jaw (ONJ).

40 Osteonecrosis of the jaws (ONJ) is a rare but severe com

41 udies have linked bisphosphonate therapy and osteonecrosis of the jaws (ONJ), but neither causality n

42 ing bisphosphonates are at greatest risk for osteonecrosis of the jaws; these patients represent 94%

43 33 (5%) patients on denosumab developed osteonecrosis of the jaw versus none on placebo.

44 A recommendation regarding osteonecrosis of the jaw was added.

45 2%] of 697 vs 172 [24%] of 704) but rates of osteonecrosis of the jaw were low in both groups (nine [

46 Seven cases of osteonecrosis of the jaw were reported in the long-term

47 No cases of osteonecrosis of the jaw were reported, and no adverse e

48 y an international expert panel, no cases of osteonecrosis of the jaw were reported.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。